{
  "trial_id": "NCT02942264",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "pathologic diagnosis of anaplastic astrocytoma",
      "label": "met",
      "evidence": "MRI showed a spinal cord conus mass which was biopsied and found to be anaplastic astrocytoma"
    },
    {
      "criterion": "recurrent disease, histologically proven or imaging suggestive of recurrent disease",
      "label": "met",
      "evidence": "Patient initially presented with RLE weakness where his right knee gave out with difficulty walking and right anterior thigh numbness."
    },
    {
      "criterion": "ability to understand and willingness to sign a written informed consent document",
      "label": "met",
      "evidence": "The patient is a 45-year-old man who can understand and sign a written informed consent document."
    },
    {
      "criterion": "age greater than or equal to 18 years old",
      "label": "met",
      "evidence": "The patient is a 45-year-old man, which meets the age criterion."
    },
    {
      "criterion": "no more than two prior disease relapses for phase I portion of study",
      "label": "unknown",
      "evidence": "Not stated"
    },
    {
      "criterion": "tumor tissue available for review to confirm histological diagnosis",
      "label": "met",
      "evidence": "Tumor block or unstained slides must be available for molecular profiling."
    },
    {
      "criterion": "adequate bone marrow function",
      "label": "unknown",
      "evidence": "Not stated"
    },
    {
      "criterion": "adequate liver function",
      "label": "unknown",
      "evidence": "Not stated"
    },
    {
      "criterion": "adequate renal function",
      "label": "unknown",
      "evidence": "Not stated"
    },
    {
      "criterion": "recovered from toxic effects of prior therapy to less than grade 2 toxicity per CTC version 4",
      "label": "unknown",
      "evidence": "Not stated"
    }
  ],
  "exclusion": [
    {
      "criterion": "prior bevacizumab use for tumor treatment",
      "label": "triggers",
      "evidence": "Patients who are receiving any other investigational agents. However, prior enrollment on a study using investigational agents is acceptable"
    },
    {
      "criterion": "receiving any other investigational agents",
      "label": "triggers",
      "evidence": "Patients who are receiving any other investigational agents"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and has undergone prior standard therapy. The patient is currently experiencing progressive lower extremity weakness and urinary retention.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT02942264",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}